When reading a lung cancer pathology report, the phrase “poorly differentiated” can be especially unsettling. It sounds ominous and vague, and patients often worry that it automatically means the worst. In reality, “poorly differentiated” is a technical term used by…
A lung biopsy is often the moment when uncertainty turns into answers. The tissue sample obtained during a biopsy allows pathologists to determine whether cancer is present and, if so, what type of lung cancer it is. But in modern…
Modern lung cancer care relies not only on what a tumor looks like under the microscope, but also on how it behaves at the molecular and immunologic level. One term that appears frequently in pathology and oncology reports is PD-L1.…
